
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $2.6B | $2.5B | $2.7B | $2.9B | $3B | |
Revenue Growth (YoY) | -4.78% | -4.19% | 11.01% | 5.07% | 3.69% | |
Cost of Revenues | $916.4M | $948.8M | $982.6M | $1B | $1.1B | |
Gross Profit | $1.7B | $1.5B | $1.8B | $1.8B | $1.9B | |
Gross Profit Margin | 64.37% | 61.49% | 64.08% | 63.59% | 63.27% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $48.3M | $56.5M | $58.7M | $60.7M | $61.7M | |
Other Inc / (Exp) | $514.3M | $1B | $290.7M | $253.1M | $472.7M | |
Operating Expenses | $869.1M | $894.8M | $940.9M | $949.4M | $1B | |
Operating Income | $786.2M | $620.4M | $811.7M | $878M | $871.7M | |
Net Interest Expenses | $368.1M | $255.5M | $289.5M | $256.2M | $263.2M | |
EBT. Incl. Unusual Items | $932.4M | $1.4B | $812.9M | $875M | $1.1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $852K | $915K | $900K | $1.1M | $1.3M | |
Net Income to Company | $962.5M | $1.4B | $807M | $868.5M | $1.1B | |
Minority Interest in Earnings | -$48.9M | -$63.9M | -$30.1M | -$33.1M | -$35.1M | |
Net Income to Common Excl Extra Items | $913.6M | $1.3B | $776.9M | $835.4M | $1B | |
Basic EPS (Cont. Ops) | $2.45 | $3.56 | $2.06 | $2.20 | $2.73 | |
Diluted EPS (Cont. Ops) | $2.45 | $3.54 | $2.05 | $2.20 | $2.72 | |
Weighted Average Basic Share | $371.8M | $373.8M | $376.2M | $378.8M | $378.8M | |
Weighted Average Diluted Share | $385.9M | $388.1M | $389.5M | $390.9M | $390.7M | |
EBITDA | $2.1B | $2.5B | $2B | $2B | $2.3B | |
EBIT | $1.3B | $1.7B | $1.1B | $1.1B | $1.4B | |
Revenue (Reported) | $2.6B | $2.5B | $2.7B | $2.9B | $3B | |
Operating Income (Reported) | $786.2M | $620.4M | $811.7M | $878M | $871.7M | |
Operating Income (Adjusted) | $1.3B | $1.7B | $1.1B | $1.1B | $1.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $597.6M | $653.3M | $705.1M | $730.8M | $760.8M | |
Revenue Growth (YoY) | -12.41% | 9.33% | 7.92% | 3.65% | 4.1% | |
Cost of Revenues | $246.7M | $256.3M | $275.7M | $279M | $291.5M | |
Gross Profit | $350.9M | $397M | $429.4M | $451.8M | $469.3M | |
Gross Profit Margin | 58.73% | 60.77% | 60.9% | 61.82% | 61.68% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $15.4M | $17.2M | $16.2M | $15.7M | $18.3M | |
Other Inc / (Exp) | -$4.2M | -$3.2M | $91.2M | $156.4M | $150M | |
Operating Expenses | $215.3M | $247.2M | $232M | $241.4M | $275M | |
Operating Income | $135.6M | $149.8M | $197.4M | $210.4M | $194.3M | |
Net Interest Expenses | $69.3M | $71.3M | $66.8M | $59.8M | $72.6M | |
EBT. Incl. Unusual Items | $62.1M | $75.3M | $221.8M | $307M | $271.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $153K | $282K | $298K | $304K | $422K | |
Net Income to Company | $60.4M | $73.8M | $220.1M | $305M | $264.8M | |
Minority Interest in Earnings | -$2.8M | -$3M | -$8M | -$9.2M | -$8.2M | |
Net Income to Common Excl Extra Items | $57.5M | $70.8M | $212M | $295.8M | $256.6M | |
Basic EPS (Cont. Ops) | $0.15 | $0.19 | $0.56 | $0.78 | $0.68 | |
Diluted EPS (Cont. Ops) | $0.15 | $0.19 | $0.56 | $0.77 | $0.67 | |
Weighted Average Basic Share | $372.3M | $375.5M | $378.3M | $378.8M | $379.2M | |
Weighted Average Diluted Share | $386.9M | $389.6M | $390.7M | $390.6M | $391.2M | |
EBITDA | $332.4M | $381.1M | $507.1M | $603.2M | $603.7M | |
EBIT | $129.5M | $148.1M | $288.2M | $374.2M | $343.8M | |
Revenue (Reported) | $597.6M | $653.3M | $705.1M | $730.8M | $760.8M | |
Operating Income (Reported) | $135.6M | $149.8M | $197.4M | $210.4M | $194.3M | |
Operating Income (Adjusted) | $129.5M | $148.1M | $288.2M | $374.2M | $343.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.5B | $2.5B | $2.8B | $2.9B | $3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $921.8M | $958.4M | $1B | $1B | $1.1B | |
Gross Profit | $1.6B | $1.6B | $1.8B | $1.8B | $1.9B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $49.2M | $58.4M | $57.6M | $60.3M | $64.2M | |
Other Inc / (Exp) | $304.7M | $1B | $600.6M | $318.4M | $466.3M | |
Operating Expenses | $857.5M | $926.6M | $925.7M | $958.8M | $1B | |
Operating Income | $707.7M | $634.7M | $859.3M | $891.1M | $855.6M | |
Net Interest Expenses | $351.7M | $257.6M | $285M | $249.1M | $276M | |
EBT. Incl. Unusual Items | $660.6M | $1.4B | $1.2B | $960.3M | $1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $952K | $1M | $916K | $1.2M | $1.4M | |
Net Income to Company | $690.2M | $1.4B | $953.3M | $953.4M | $1B | |
Minority Interest in Earnings | -$27.6M | -$64.1M | -$35.1M | -$34.3M | -$34.1M | |
Net Income to Common Excl Extra Items | $662.6M | $1.3B | $918.2M | $919.2M | $996.6M | |
Basic EPS (Cont. Ops) | $1.77 | $3.58 | $2.43 | $2.42 | $2.63 | |
Diluted EPS (Cont. Ops) | $1.77 | $3.58 | $2.43 | $2.41 | $2.62 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.8B | $2.6B | $2.3B | $2.1B | $2.3B | |
EBIT | $1B | $1.7B | $1.5B | $1.2B | $1.3B | |
Revenue (Reported) | $2.5B | $2.5B | $2.8B | $2.9B | $3B | |
Operating Income (Reported) | $707.7M | $634.7M | $859.3M | $891.1M | $855.6M | |
Operating Income (Adjusted) | $1B | $1.7B | $1.5B | $1.2B | $1.3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $597.6M | $653.3M | $705.1M | $730.8M | $760.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $246.7M | $256.3M | $275.7M | $279M | $291.5M | |
Gross Profit | $350.9M | $397M | $429.4M | $451.8M | $469.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $15.4M | $17.2M | $16.2M | $15.7M | $18.3M | |
Other Inc / (Exp) | -$4.2M | -$3.2M | $91.2M | $156.4M | $150M | |
Operating Expenses | $215.3M | $247.2M | $232M | $241.4M | $275M | |
Operating Income | $135.6M | $149.8M | $197.4M | $210.4M | $194.3M | |
Net Interest Expenses | $69.3M | $71.3M | $66.8M | $59.8M | $72.6M | |
EBT. Incl. Unusual Items | $62.1M | $75.3M | $221.8M | $307M | $271.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $153K | $282K | $298K | $304K | $422K | |
Net Income to Company | $60.4M | $73.8M | $220.1M | $305M | $264.8M | |
Minority Interest in Earnings | -$2.8M | -$3M | -$8M | -$9.2M | -$8.2M | |
Net Income to Common Excl Extra Items | $57.5M | $70.8M | $212M | $295.8M | $256.6M | |
Basic EPS (Cont. Ops) | $0.15 | $0.19 | $0.56 | $0.78 | $0.68 | |
Diluted EPS (Cont. Ops) | $0.15 | $0.19 | $0.56 | $0.77 | $0.67 | |
Weighted Average Basic Share | $372.3M | $375.5M | $378.3M | $378.8M | $379.2M | |
Weighted Average Diluted Share | $386.9M | $389.6M | $390.7M | $390.6M | $391.2M | |
EBITDA | $332.4M | $381.1M | $507.1M | $603.2M | $603.7M | |
EBIT | $129.5M | $148.1M | $288.2M | $374.2M | $343.8M | |
Revenue (Reported) | $597.6M | $653.3M | $705.1M | $730.8M | $760.8M | |
Operating Income (Reported) | $135.6M | $149.8M | $197.4M | $210.4M | $194.3M | |
Operating Income (Adjusted) | $129.5M | $148.1M | $288.2M | $374.2M | $343.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $42.6M | $123.8M | $53.9M | $50.7M | $62.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $99.7M | $360.2M | $137.2M | $140M | $160.2M | |
Property Plant And Equipment | $499.3M | $474.7M | $463M | $457.3M | $455.4M | |
Long-Term Investments | $52.8M | $127.4M | $279M | $282M | $386.5M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $291.4M | $288.2M | $278.2M | $253M | $273.7M | |
Total Assets | $20.3B | $21.2B | $20.2B | $20B | $20.8B | |
Accounts Payable | $107.4M | $107M | $96M | $87.4M | $99.3M | |
Accrued Expenses | $65.9M | $69.5M | $66.3M | $65.7M | $74.2M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $820.4M | $725.1M | $536.9M | $821.5M | $980.7M | |
Long-Term Debt | $7.6B | $8B | $7.3B | $7B | $7.6B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $9.2B | $9.5B | $8.5B | $8.5B | $9.2B | |
Common Stock | $41M | $41M | $41.1M | $41.1M | $21M | |
Other Common Equity Adj | -$43.7M | -$34.3M | -$2.5M | $5.7M | $4.2M | |
Common Equity | $10.5B | $10.9B | $11.1B | $11B | $11B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $576.8M | $731.2M | $527.5M | $492.5M | $539.8M | |
Total Equity | $11.1B | $11.7B | $11.7B | $11.6B | $11.6B | |
Total Liabilities and Equity | $20.3B | $21.2B | $20.2B | $20B | $20.8B | |
Cash and Short Terms | $42.6M | $123.8M | $53.9M | $50.7M | $62.3M | |
Total Debt | $8B | $8.3B | $7.4B | $7.4B | $8.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $35.5M | $41.1M | $133.5M | $44.5M | $39.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $97.8M | $111.7M | $219.1M | $196.6M | $141.5M | |
Property Plant And Equipment | $485M | $471.7M | $466.9M | $454M | $452.8M | |
Long-Term Investments | $53.3M | $150.1M | $292.3M | $289.3M | $412M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $290.7M | $238M | $235M | $231.8M | $231.3M | |
Total Assets | $20.2B | $20.8B | $20.1B | $19.9B | $20.6B | |
Accounts Payable | $168M | $157.7M | $144.7M | $146.1M | $149.3M | |
Accrued Expenses | $55.5M | $56.9M | $49.8M | $49.2M | $50.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $886M | $587.1M | $453.4M | $684.8M | $774.3M | |
Long-Term Debt | $7.6B | $8B | $7.3B | $7B | $7.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $9.2B | $9.3B | $8.4B | $8.3B | $9B | |
Common Stock | $41M | $41M | $41.1M | $20.9M | $21M | |
Other Common Equity Adj | -$41.4M | -$31.8M | -$11.2M | $6.3M | $3.4M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -$21.6M | -- | |
Minority Interest, Total | $647M | $716.6M | $532.7M | $504.4M | $541.8M | |
Total Equity | $11B | $11.5B | $11.7B | $11.6B | $11.6B | |
Total Liabilities and Equity | $20.2B | $20.8B | $20.1B | $19.9B | $20.6B | |
Cash and Short Terms | $35.5M | $41.1M | $133.5M | $44.5M | $39.8M | |
Total Debt | $8B | $8.2B | $7.3B | $7.2B | $7.8B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $962.5M | $1.4B | $807M | $868.5M | $1.1B | |
Depreciation & Amoritzation | $832.4M | $851.4M | $894.3M | $901.5M | $966.7M | |
Stock-Based Compensation | $23.2M | $27.8M | $29.5M | $31.8M | $31.3M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.3B | $1.3B | $1.5B | $1.5B | $1.6B | |
Capital Expenditures | $166.2M | $168.6M | $232.2M | $333.5M | $318.7M | |
Cash Acquisitions | -$5.8M | -$79.8M | -$159.7M | -$47.9M | -$109.7M | |
Cash From Investing | $663.6M | -$434.6M | $107.8M | -$409.5M | -$1.2B | |
Dividends Paid (Ex Special Dividend) | -$887M | -$903.6M | -$934.1M | -$993.2M | -$1B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $9.8B | $8.2B | $6.1B | $6.7B | $34.1B | |
Long-Term Debt Repaid | -$10.8B | -$7.9B | -$7B | -$6.8B | -$33.4B | |
Repurchase of Common Stock | -- | -- | -- | -$49.1M | -$60M | |
Other Financing Activities | -$74.1M | -$42.7M | -$91M | -$18.7M | -$45.5M | |
Cash From Financing | -$1.9B | -$565.1M | -$1.8B | -$1.1B | -$377M | |
Beginning Cash (CF) | $117M | $99.7M | $360.2M | $137.2M | $140M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$17.3M | $260.5M | -$223.1M | $2.8M | $20.2M | |
Ending Cash (CF) | $99.7M | $360.2M | $137.2M | $140M | $160.2M | |
Levered Free Cash Flow | $1.1B | $1.1B | $1.2B | $1.2B | $1.3B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $328M | $232.7M | $144.9M | $183.6M | -- | |
Depreciation & Amoritzation | $204.9M | $226.9M | $224.6M | $227.6M | -- | |
Stock-Based Compensation | $7.4M | $9.4M | $11.8M | $11.9M | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $230.1M | $322.8M | $352.7M | $396.9M | -- | |
Capital Expenditures | $42.6M | $49.3M | $83.9M | $83.9M | -- | |
Cash Acquisitions | -$2.1M | -$23.7M | -$11.9M | -$52.3M | -- | |
Cash From Investing | $71M | $151.7M | -$315M | -$138.4M | -- | |
Dividends Paid (Ex Special Dividend) | -$225.4M | -$235.7M | -$251.7M | -$256.1M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $1.6B | $1.4B | $1.1B | $2.3B | -- | |
Long-Term Debt Repaid | -$1.4B | -$1.6B | -$940.4M | -$2.4B | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$9M | -$41.7M | -$12.2M | -$7.7M | -- | |
Cash From Financing | -$6.4M | -$467.6M | -$132.1M | -$316.7M | -- | |
Beginning Cash (CF) | $97.8M | $111.7M | $219.1M | $196.6M | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $294.7M | $7M | -$94.4M | -$58.1M | -- | |
Ending Cash (CF) | $392.5M | $118.7M | $124.6M | $138.4M | -- | |
Levered Free Cash Flow | $187.4M | $273.5M | $268.8M | $313M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $690.2M | $1.4B | $953.3M | $953.4M | $1B | |
Depreciation & Amoritzation | $820M | $881.5M | $880.3M | $911.5M | $997.7M | |
Stock-Based Compensation | $24M | $28.3M | $29.4M | $32.2M | $32.2M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.2B | $1.3B | $1.5B | $1.6B | $1.6B | |
Capital Expenditures | $154.6M | $172.9M | $254.4M | $351.4M | $308.3M | |
Cash Acquisitions | -$2.7M | -$102.3M | -$149.3M | -$41.2M | -$134.2M | |
Cash From Investing | $271.2M | -$505.3M | $348.6M | -$317.2M | -$1.2B | |
Dividends Paid (Ex Special Dividend) | -$900.1M | -$905.9M | -$944.8M | -$1B | -$1B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $8.4B | $8.4B | $6B | $6.5B | $44.2B | |
Long-Term Debt Repaid | -$9B | -$8.2B | -$6.9B | -$6.7B | -$43.5B | |
Repurchase of Common Stock | -- | -- | -- | -$109.1M | -- | |
Other Financing Activities | -$68.1M | -$54M | -$78M | -$19M | -$47M | |
Cash From Financing | -$1.5B | -$763M | -$1.7B | -$1.3B | -$418M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$42.9M | $13.9M | $107.4M | -$22.5M | -$55M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $1.1B | $1.1B | $1.2B | $1.2B | $1.3B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $388.4M | $306.5M | $364.9M | $488.6M | $264.8M | |
Depreciation & Amoritzation | $407.8M | $459.9M | $443.5M | $456.6M | $259.9M | |
Stock-Based Compensation | $16.1M | $18.6M | $20.8M | $21.4M | $10.4M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $576.1M | $690.9M | $746M | $818M | $425.5M | |
Capital Expenditures | $75.7M | $86.6M | $143.3M | $161.1M | $66.8M | |
Cash Acquisitions | -$4.5M | -$48.6M | -$26.4M | -$60.1M | -$32.3M | |
Cash From Investing | -$55.4M | -$45.3M | -$271.3M | -$2.4M | $97.3M | |
Dividends Paid (Ex Special Dividend) | -$450.5M | -$463.2M | -$489.8M | -$508.4M | -$256.8M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $2.9B | $2.9B | $2.4B | $3.5B | $11.2B | |
Long-Term Debt Repaid | -$2.7B | -$3.2B | -$2.4B | -$3.8B | -$11.5B | |
Repurchase of Common Stock | -- | -- | -- | -$60M | -- | |
Other Financing Activities | -$20.6M | -$64.7M | -$22.2M | -$18M | -$11.7M | |
Cash From Financing | -$228M | -$887.1M | -$487.2M | -$817.2M | -$541.5M | |
Beginning Cash (CF) | $197.6M | $471.9M | $356.3M | $336.6M | $160.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $292.8M | -$241.6M | -$12.5M | -$1.6M | -$18.6M | |
Ending Cash (CF) | $490.3M | $230.4M | $343.7M | $335M | $141.5M | |
Levered Free Cash Flow | $500.5M | $604.3M | $602.7M | $656.8M | $358.7M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.